logo

For the Inventor, By the Inventor

North Wales, PA, United States of America

William M Hurni

This inventor holds 13 USPTO granted patents. Top assignee: Merck + Co., Inc.. Active years: 1977-1992.

IDiyas Innovation Intelligence. (2026). Inventor Profile: William M Hurni. Retrieved from https://idiyas.com/inventor/william-m-hurni

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 13

% Patents Active = 100.0

Average Co-Inventor Count = 2.1

ph-index = 7

Forward Citations = 115(Granted Patents)


Company Filing History:

goldMedal13 out of 4,770 
 
Merck + Co., Inc.
 patents

Years Active: 1977-1992

Loading Chart...
13 patents (USPTO):Explore Patents
1. 5091300 - Radio-immuno assay for hepatitis B virus PreS2 antibodies (1992-02-25),
2. 4861706 - Assay for hepatitis a virus (1989-08-29),
3. 4382076 - Hepatitis A antibody assay (1983-05-03),
4. 4319271 - Automated plate reader (1982-03-09),
5. 4293538 - Assay for hepatitis A antigen (1981-10-06),
6. 4242457 - Automated virus harvesting (1980-12-30),
7. 4217418 - Recovery of small particles by flow centrifugation (1980-08-12),
8. 4187989 - Method for recovering embryos from embryonated eggs (1980-02-12),
9. 4115010 - Automated plate reader (1978-09-19),
10. 4110223 - Apparatus for recovering embryos from embryonated eggs (1978-08-29),
11. 4065359 - Cell removing device (1977-12-27),
12. 4028190 - Apparatus for preparing isolated cells from tissue (1977-06-07),
13. 4004981 - Cell removing device (1977-01-25),

Title: The Innovations of William M Hurni

Introduction

William M Hurni is a notable inventor based in North Wales, Pennsylvania. He has made significant contributions to the field of medical diagnostics, particularly in the area of hepatitis virus assays. With a total of 13 patents to his name, Hurni's work has had a profound impact on the detection and understanding of hepatitis viruses.

Latest Patents

Among his latest patents is a radio-immuno assay for hepatitis B virus PreS2 antibodies. This innovative assay involves the adsorption of anti-hepatitis B virus surface protein (anti-HBS) antibody onto a substratum. The hepatitis B virus PreS2+S protein is then adsorbed onto the same surface, allowing for the detection of antibodies. Another significant patent is for a quantitative assay for hepatitis A virus (HAV). This assay involves infecting a cell sheet with a dilution series of HAV and utilizing Newcastle disease virus (NDV) to determine the presence of HAV based on cytopathic effects observed at specific incubation temperatures.

Career Highlights

William M Hurni is currently employed at Merck & Company, Inc., where he continues to advance his research and development efforts. His work at Merck has allowed him to collaborate with other talented professionals in the field, further enhancing the impact of his inventions.

Collaborations

Some of Hurni's notable coworkers include William J McAleer and William J Miller. Their collaborative efforts have contributed to the success of various projects and innovations within the company.

Conclusion

William M Hurni's contributions to medical diagnostics, particularly in hepatitis virus detection, showcase his innovative spirit and dedication to improving public health. His patents reflect a commitment to advancing scientific knowledge and technology in the medical field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…